A practical synthesis of multitargeted antifolate LY231514

被引:34
|
作者
Barnett, CJ [1 ]
Wilson, TM [1 ]
Kobierski, ME [1 ]
机构
[1] Lilly Res Labs, Clin Proc Res & Dev Div, Indianapolis, IN 46285 USA
关键词
D O I
10.1021/op9802172
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A concise and scalable synthesis of LY231514 (1), a new pyrrolo[2,3-d]pyrimidine-based antitumor agent, is presented. Reaction of 2-bromo-4-arylbutanal 9 with 2,4-diamino-6-hydroxypyrimidine (10) regioselectively provided pyrrolo[2,3-d] pyrimidine 11, representing the core structure of the drug, in good yield. Assimilation of the glutamic acid residue by conventional means completed the synthesis. Development of the optimized synthetic route emphasized avoiding isolation of the relatively unstable aldehyde and bromoaldehyde intermediates.
引用
收藏
页码:184 / 188
页数:5
相关论文
共 50 条
  • [1] Glutamyl hydrolase and the multitargeted antifolate LY231514
    Rhee, MS
    Ryan, TJ
    Galivan, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (05) : 427 - 432
  • [2] Glutamyl hydrolase and the multitargeted antifolate LY231514
    Myung S. Rhee
    Thomas J. Ryan
    John Galivan
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 427 - 432
  • [3] Synthetic approaches to multitargeted antifolate LY231514
    Barnett, CJ
    Wilson, TM
    Kobierski, ME
    CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, 1997, : 123 - 126
  • [4] Biochemical pharmacology studies of a multitargeted antifolate: LY231514
    Shih, C
    Beardsley, GP
    Chen, VJ
    Ehlhardt, WJ
    MacKellar, WC
    Mendelsohn, LG
    Ratnam, M
    Schultz, RM
    Taylor, EC
    Worzalla, JF
    CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, 1997, : 181 - 187
  • [5] A Phase I and pharmacokinetic study of LY231514, the multitargeted antifolate
    McDonald, AC
    Vasey, PA
    Adams, L
    Walling, J
    Woodworth, JR
    Abrahams, T
    McCarthy, S
    Bailey, NP
    Siddiqui, N
    Lind, MJ
    Calvert, AH
    Twelves, CJ
    Cassidy, J
    Kaye, SB
    CLINICAL CANCER RESEARCH, 1998, 4 (03) : 605 - 610
  • [6] Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay
    Carolyn D. Britten
    Elzbieta Izbicka
    Susan Hilsenbeck
    Richard Lawrence
    Karen Davidson
    Caeser Cerna
    Lionel Gomez
    Eric K. Rowinsky
    Steven Weitman
    Daniel D. Von Hoff
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 105 - 110
  • [7] Overview of Phase I trials of multitargeted antifolate (MTA, LY231514)
    Rinaldi, DA
    SEMINARS IN ONCOLOGY, 1999, 26 (02) : 82 - 88
  • [8] Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay
    Britten, CD
    Izbicka, E
    Hilsenbeck, S
    Lawrence, R
    Davidson, K
    Cerna, C
    Gomez, L
    Rowinsky, EK
    Weitman, S
    Von Hoff, DD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) : 105 - 110
  • [9] Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514
    Schultz, RM
    Patel, VF
    Worzalla, JF
    Shih, CA
    ANTICANCER RESEARCH, 1999, 19 (1A) : 437 - 443
  • [10] Phase II studies in solid tumors with LY231514, a multitargeted antifolate (MTA)
    Thornton, DE
    John, W
    Loerher, P
    Eisenhauer, E
    CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, 1997, : 195 - 200